Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Callander, Natalie
[Clear All Filters]
2023
Chung DJ
,
Shah N
,
Wu J
,
Logan B
,
Bisharat L
,
Callander N
,
Cheloni G
,
Anderson K
,
Chodon T
,
Dhakal B
, et al.
Randomized Trial of a Personalized Dendritic Cell Vaccine after Autologous Stem Cell Transplant for Multiple Myeloma.
Clin Cancer Res. 2023.
PubMed
Google Scholar
Kenkre VP
,
Bradley K
,
Milton A
,
Burkholder JK
,
Grindle K
,
McMannes J
,
Kim KM
,
Callander N
,
Juckett M
,
Longo W
, et al.
TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience.
Leuk Lymphoma. 2023:1-5.
PubMed
Google Scholar
2022
Chhabra S
,
Callander N
,
Watts NL
,
Costa LJ
,
Thapa B
,
Kaufman JL
,
Laubach J
,
Sborov DW
,
Reeves B
,
Rodríguez C
, et al.
Stem cell mobilization yields with daratumumab and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma: findings from the MASTER and GRIFFIN trials.
Transplant Cell Ther. 2022.
PubMed
Google Scholar
2020
Kumar SK
,
Jacobus SJ
,
Cohen AD
,
Weiss M
,
Callander N
,
Singh AK
,
Parker TL
,
Menter A
,
Yang X
,
Parsons B
, et al.
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomise
. Lancet Oncol. 2020.
PubMed
Google Scholar
D'Angelo CR
,
Hall A
,
Woo KM
,
Kim KM
,
Longo W
,
Hematti P
,
Callander N
,
Kenkre VP
,
Mattison R
,
Juckett M
.
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications.
Leuk Res. 2020;96:106419.
PubMed
Google Scholar
2018
Inamoto Y
,
Petriček I
,
Burns L
,
Chhabra S
,
DeFilipp Z
,
Hematti P
,
Rovó A
,
Schears R
,
Shah A
,
Agrawal V
, et al.
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
Biol Blood Marrow Transplant. 2018.
PubMed
Google Scholar
2015
Shah N
,
Callander N
,
Ganguly S
,
Gul Z
,
Hamadani M
,
Costa L
,
Sengsayadeth S
,
Abidi M
,
Hari P
,
Mohty M
, et al.
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the ASBMT.
Biol Blood Marrow Transplant. 2015.
PubMed
Google Scholar